HYDROMORPHON
Acute Cerebrovascular Accident
University of FloridaSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Acute Cerebrovascular Accident cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dextromethorphan University of Florida | Phase 4 | BBB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Beijing Tiantan Hospital | Phase 3 | BB |
Nimodipine University of Florida | Phase 4 | BB |
Conivaptan Jesse Corry | Phase 2 | B |
Benadryl Global Neurosciences Institute | Phase 2 | B |
View all 9 →
Same molecule, other indications
HYDROMORPHON is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →